fda import alert 66-80 glp-1 green list creates "green list" to block unsafe imports | FDA posted on the topic fda green list import alert
Description
Injectable GLP-1 medications can be administered without regard to meals, while oral semaglutide must be taken on an empty stomach with a small amount of water, at least 30 minutes before eating or taking other medicines
Recent studies suggest a potential association between semaglutide, a GLP-1 receptor agonist for type 2 diabetes and obesity, and an increased risk of NAION
The balanced plate model is a practical way to hit these targets without counting anything

Ensure adequate protein intake (1.6-2.2g per kg of body weight)
doi: 10.1254/jphs.12270FP